Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Down 89.5% in February

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 400 shares, a drop of 89.5% from the January 31st total of 3,800 shares. Based on an average daily volume of 5,400 shares, the short-interest ratio is currently 0.1 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC grew its holdings in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 7.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 65,883 shares of the company’s stock after buying an additional 4,541 shares during the period. Jane Street Group LLC owned approximately 3.14% of Fidelity Disruptive Medicine ETF worth $1,625,000 as of its most recent filing with the Securities & Exchange Commission.

Fidelity Disruptive Medicine ETF Stock Performance

Shares of NASDAQ:FMED traded up $0.18 during trading on Friday, reaching $25.17. 3,974 shares of the stock traded hands, compared to its average volume of 5,510. Fidelity Disruptive Medicine ETF has a 52-week low of $23.32 and a 52-week high of $26.79. The stock has a 50-day moving average of $25.64 and a two-hundred day moving average of $25.78. The stock has a market cap of $52.86 million, a P/E ratio of 43.85 and a beta of 0.94.

Fidelity Disruptive Medicine ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Friday, December 20th were paid a dividend of $0.112 per share. This represents a $0.45 annualized dividend and a dividend yield of 1.78%. The ex-dividend date was Friday, December 20th. This is a boost from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.00.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.